SCHEMBL21066299

SCHEMBL21066299

Cc1cccc(P(=O)(Cl)c2cccc(C)c2)c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 5/20 0.48
ACP3 P15309 1/20 0.43
PTPN5 P54829 1/20 0.40
HDAC8 Q9BY41 1/20 0.39
HDAC6 Q9UBN7 1/20 0.39
HPGD P15428 1/20 0.39
ALDH1A1 P00352 1/20 0.39
MAPK1 P28482 1/20 0.39
NPC1 O15118 3/20 0.39
CASP3 P42574 1/20 0.39
SENP8 Q96LD8 1/20 0.39
SENP7 Q9BQF6 1/20 0.39
SENP6 Q9GZR1 1/20 0.39
RAB9A P51151 2/20 0.38
MEN1 O00255 1/20 0.38
KMT2A Q03164 1/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
PARP1 P09874 1/20 0.38
TSHR P16473 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11222577 0.86 ACHE (0.48) ACHEACP3HDAC8HDAC6HPGD
SCHEMBL29968470 0.81 ACHE (0.52) ACHEACP3HDAC8HDAC6HPGD
SCHEMBL1003285 0.81 ACHE (0.52) ACHEACP3HDAC8HDAC6HPGD
SCHEMBL3893074 0.79 ACHE (0.50) ACHEACP3HDAC8HDAC6HPGD
SCHEMBL30529848 0.77 ACHE (0.48) ACHEACP3PTPN5HDAC8HDAC6
SCHEMBL28663167 0.77 ACHE (0.48) ACHEACP3PTPN5HDAC8HDAC6
SCHEMBL29080990 0.77 ACHE (0.48) ACHEACP3PTPN5HDAC8HDAC6
SCHEMBL14339300 0.77 ACHE (0.48) ACHEACP3HDAC8HDAC6HPGD
SCHEMBL3355826 0.77 CA2 (0.52) ACHEACP3PTPN5HDAC8HDAC6
SCHEMBL971683 0.77 LMNA (0.54) ACHEACP3PTPN5HDAC8HDAC6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109970791-B Indenotriphenylene derivative and organic electroluminescent device using the same 机光科技股份有限公司 2022-07-22 CN disclosed
US-10428269-B2 Indenotriphenylene derivative and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-10-01 US disclosed
US-10428269-B2 Indenotriphenylene derivative and organic electroluminescence device using the same LUMINESCENCE TECHNOLOGY CORP. (TW) 2019-10-01 US disclosed
WO-2019181645-A1 COMPOUND, PRECURSOR TO COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL INCLUDING COMPOUND, AND ORGANIC ELECTRONIC DEVICE INCLUDING ORGANIC SEMICONDUCTOR MATERIAL 国立大学法人大阪大学 2019-09-26 WO disclosed
WO-2019181646-A1 MACROMOLECULAR COMPOUND, ORGANIC SEMICONDUCTOR MATERIAL INCLUDING MACROMOLECULAR COMPOUND, AND ORGANIC ELECTRONIC DEVICE INCLUDING ORGANIC SEMICONDUCTOR MATERIAL 国立大学法人大阪大学 2019-09-26 WO disclosed
CN-109970791-A Indeno Sanya benzene derivative and the organic electroluminescent element for using it 机光科技股份有限公司 2019-07-05 CN disclosed
US-20190194534-A1 INDENOTRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-06-27 US disclosed
US-20190194534-A1 INDENOTRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME LUMINESCENCE TECHNOLOGY CORPORATION (TW) 2019-06-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190194534-A1 INDENOTRIPHENYLENE DERIVATIVE AND ORGANIC ELECTROLUMINESCENCE DEVICE USING THE SAME ICMT, INCENP, ITPA ACHE 1047/4885ACP3 3177/4885PTPN5 2859/4885
US-10428269-B2 Indenotriphenylene derivative and organic electroluminescence device using the same ICMT, INCENP, ITPA ACHE 1047/4885ACP3 3177/4885PTPN5 2859/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.